Concert Pharma Q2 Net Loss Slightly Narrows

Concert Pharmaceuticals Inc. (CNCE) Tuesday announced net loss of $13.03 million for the second quarter, narrower than net loss of $13.44 million last year. On a per share basis, loss narrowed to $0.58 from $0.60 per share.

On average, 5 analysts polled by Thomson Reuters expected the company to record loss of $0.66 per share. Analysts estimates usually exclude special items.

Total revenue for the quarter fell to $15 thousand from $71 thousand last year. Wall Street expected the company to report revenue of $50K.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT